Breast Cancer Risk
18
5
7
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 18 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 9 completed trials
Clinical Trials (18)
Genetic Assessment of Breast Cancer Risk in Women in the DORA Programme
Peer Support For Young Adult Women With High Breast Cancer Risk
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
Rutgers University Study of the Genetics of Breast Cancer.
Effect of Web-based Nursing Navigator Programme on Breast Cancer Screening Behaviors in Women at High Risk of Breast Cancer
Development of New Methodologies and Innovative Tools for the diagnoSi and Therapeutic Treatment of uMAni Epithelial Tumors
Population Based Germline Testing for Early Detection and Prevention of Cancer
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
Family-Based Intervention Study of the Effects of Environmental Exposures on Breast Tissue Composition
Uptake of Genetic Counseling Among African American Women
EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality
A Randomized Controlled Trial to Increase Breast Cancer Screening Uptake
The RISC Registry--Risk Informed Screening Registry
FH-Risk 2.0: Updating Breast Cancer Risk Estimates
Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer
Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk
The Effects of Equivalent Weight Loss With or Without Exercise Training on Breast Cancer Risk (SHAPE-2)
Soy, Selenium and Breast Cancer Risk